These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8676751)

  • 21. Muscarinic agonists for senile dementia: past experience and future trends.
    Gray JA; Enz A; Spiegel R
    Trends Pharmacol Sci; 1989 Dec; Suppl():85-8. PubMed ID: 2694530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dementia and antiphospholipid antibodies.
    Mosek A; Yust I; Treves TA; Vardinon N; Korczyn AD; Chapman J
    Dement Geriatr Cogn Disord; 2000; 11(1):36-8. PubMed ID: 10629360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA antigens in Alzheimer's disease.
    Reed E; Thompson D; Mayeaux R; Suciu-Foca N
    Tissue Antigens; 1983 Feb; 21(2):164-7. PubMed ID: 6845343
    [No Abstract]   [Full Text] [Related]  

  • 24. Histocompatibility antigens (HLA) and patterns of cognitive loss in dementia of the Alzheimer type.
    Cohen D; Eisdorfer C; Walford RL
    Neurobiol Aging; 1981; 2(4):277-80. PubMed ID: 7335146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of major depression on clinical and psychometric assessment of senile dementia of the Alzheimer type.
    Rubin EH; Kinscherf DA; Grant EA; Storandt M
    Am J Psychiatry; 1991 Sep; 148(9):1164-71. PubMed ID: 1882993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic management of Alzheimer-type dementia.
    Volicer L; Herz LR
    Am Fam Physician; 1985 Jul; 32(1):123-8. PubMed ID: 2861736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual evoked potentials (VEPs) in senile dementia (Alzheimer type) and in non-organic behavioural disorders in the elderly; comparison with EEG parameters.
    Visser SL; Van Tilburg W; Hooijer C; Jonker C; De Rijke W
    Electroencephalogr Clin Neurophysiol; 1985 Feb; 60(2):115-21. PubMed ID: 2578362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological factors in senile dementia.
    Kellett JM; Martin JM; Fry AH
    Acta Psychiatr Scand; 1982 Nov; 66(5):341-9. PubMed ID: 7180559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques.
    Ishii T; Haga S
    Acta Neuropathol; 1976 Nov; 36(3):243-9. PubMed ID: 795258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating senile dementia of Alzheimer type and multi-infarct dementia by proton NMR imaging.
    Besson JA; Corrigan FM; Foreman EI; Ashcroft GW; Eastwood LM; Smith FW
    Lancet; 1983 Oct; 2(8353):789. PubMed ID: 6137619
    [No Abstract]   [Full Text] [Related]  

  • 31. Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations.
    Patterson CJ; Gauthier S; Bergman H; Cohen CA; Feightner JW; Feldman H; Hogan DB
    CMAJ; 1999 Jun; 160(12):1738-42. PubMed ID: 10410640
    [No Abstract]   [Full Text] [Related]  

  • 32. [Etiopathogenetic concepts in senile dementia of the Alzheimer type].
    Fărcăşel L; Chiriac ME
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):493-5. PubMed ID: 3074434
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological studies in senile dementia of the Alzheimer type: evidence for enhanced suppressor cell activity.
    Miller AE; Neighbour PA; Katzman R; Aronson M; Lipkowitz R
    Ann Neurol; 1981 Dec; 10(6):506-10. PubMed ID: 6173011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population.
    Berg L; Hughes CP; Coben LA; Danziger WL; Martin RL; Knesevich J
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):962-8. PubMed ID: 7175540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological verification of ischemic score in differentiation of dementias.
    Rosen WG; Terry RD; Fuld PA; Katzman R; Peck A
    Ann Neurol; 1980 May; 7(5):486-8. PubMed ID: 7396427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dementia diseases--a systematic review. SBU's summary and conclusions].
    Edhag O; Norlund A
    Lakartidningen; 2006 Jul 12-25; 103(28-29):2135-9. PubMed ID: 16895096
    [No Abstract]   [Full Text] [Related]  

  • 37. What do we know about Alzheimer's disease today? An overview.
    Lauter H
    Dan Med Bull; 1985 Feb; 32 Suppl 1():1-21. PubMed ID: 2859146
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological indices in the cerebrospinal fluid of patients with presenile dementia of the Alzheimer type.
    Jonker C; Eikelenboom P; Tavenier P
    Br J Psychiatry; 1982 Jan; 140():44-9. PubMed ID: 7059740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive frailty: a potential target for secondary prevention of dementia.
    Panza F; Lozupone M; Solfrizzi V; Stallone R; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1023-1027. PubMed ID: 28849681
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type.
    Perry RH; Wilson ID; Bober MJ; Atack J; Blessed G; Tomlinson BE; Perry EK
    Lancet; 1982 Jan; 1(8264):174-5. PubMed ID: 6119555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.